References
- Rezk M, Sayyed T, Masood A, et al. Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS. Eur J Contracept Reprod Health Care. 2017;22:344–348.
- Roy S. Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol. 1991;165:1240–1244.
- Kiriwat O, Boriboonhirunsarn D. Prevalence of BV among intrauterine device users in Thai women attending family planning clinic, Siriraj Hospital. J Med Assoc Thai. 2004;87(Suppl 3):S8–S11.
- Madden T, Grentzer JM, Secura GM, et al. Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis. 2012;39:217–222.
- Joesoef MR, Karundeng A, Runtupalit C, et al. High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception. 2001;64:169–172.
- Parewijck W, Claeys G, Thiery M, et al. Candidiasis in women fitted with an intrauterine contraceptive device. Br J Obstet Gynaecol. 1988;95:408–410.
- Neale R, Knight I, Keane F. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device? Int J STD AIDS. 2009;20:423–424.
- Sexually Transmitted Diseases Treatment Guidelines. 2010 [cited 2017 October 27]. Available from: https://www.cdc.gov/std/treatment/2010/STD-Treatment-2010-RR5912.pdf#page=60